Singapore, 18th of February, 2023 – CNI is pleased to announce the successful delivery of the process vessel package commissioned by Daelim E&C for Cariflex’s new Polyisoprene Latex Plant in Singapore. This milestone marks a significant step forward in the development of the world’s largest and Singapore’s first polyisoprene latex production facility.
The delivered package includes a comprehensive range of critical process vessels: Isoprene Vessel, Column, Reactor, Storage Vessel, Blending Vessel, Cement Transfer Vessel, Flare Knock-out Drum, Pasteurization Vessel, Latex Surge Vessel, Recovered Cyclopentane Vessel and Hot Waste Vessel
Cariflex’s investment in the Singapore plant underscores its dedication to innovation and leadership in the IR Latex market. The new facility will significantly bolster the company’s ability to meet the growing demand for high-quality, synthetic latex products in the region and beyond. This new plant represents Cariflex’s largest capacity expansion, driven by a strong commitment to better serve its global customers in the medical and consumer products sectors.
Cariflex’s polyisoprene rubber latex (Cariflex™ IR Latex) is a synthetic, water-based polymer latex, ideal for various high-value applications. It is particularly valued in the production of surgical gloves and condoms, offering a unique alternative to natural rubber latex. The Singapore plant will enhance Cariflex’s manufacturing supply capabilities, specifically targeting Southeast Asia, home to many of the world’s key manufacturing facilities for surgical gloves and condoms.
About Cariflex
Cariflex is a global leader in the production of isoprene rubber latex (IR Latex) and isoprene rubber (IR), serving medical and other high-value markets. Known for its commitment to quality and innovation, Cariflex offers products that provide superior performance and safety, meeting the stringent requirements of its global customer base.
Cariflex là công ty dẫn đầu toàn cầu về mủ cao su isopren (“IR Latex”) và cao su isoprene (“IR”) cho các thị trường y tế cuối cùng và các thị trường có giá trị cao khác với động lực tăng trưởng mạnh mẽ.